A group of doctors is urging officials in Nunavut to offer an effective but costly drug to all Inuit babies living in remote communities in the territory to protect them against a respiratory virus that disproportionately leads to their hospitalization.

A petition, started by members of the 1989 graduating class of University of Toronto’s faculty of medicine, says giving the prophylaxis palivizumab to Inuit infants would reduce their rates of serious complications from respiratory syncytial virus (RSV) and would also save the government money it currently spends on air-ambulance services and hospital stays.

But Nunavut’s chief medical officer disagrees, saying there isn’t enough evidence to support such an approach.

Read more…